Ładuje się......
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
Combining immunotherapy with targeted therapy has increasingly become an appealing therapeutic paradigm for cancer treatment due to its great potential for generating durable and synergistic antitumor response. In this study, however, we unexpectedly found that two types of CpG-based tumor peptide v...
Zapisane w:
| Wydane w: | Oncogene |
|---|---|
| Główni autorzy: | , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5509483/ https://ncbi.nlm.nih.gov/pubmed/28263973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.35 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|